Scientific Reports · 2022 · 11 citations · 18 references
Life SciencesGeneticsOphthalmologyHuman GeneticsMedical GeneticsOcular DiseaseFluorescein AngiographyMacular DiseaseMacular DisordersAutofluorescenceChoroidal Thickness VariationFluorescein Angiography FindingsFundus Fluorescein AngiographyOcular Fundus AutofluorescenceRetinal Thickness AnalysisSubfoveal Choroidal ThicknessTaqman Genotyping Assays
Abstract To investigate the differences in clinical and genetic characteristics between males and females with central serous chorioretinopathy (CSC). Consecutive 302 patients (mean age; 56.3 ± 11.7, male/female: 249/53) with CSC were evaluated on the initial presentation. All CSC patients underwent fluorescein angiography and indocyanine green angiography (FA/ICGA), swept-source or spectral-domain optical coherence tomography (OCT), and fundus autofluorescence (FAF) to confirm a diagnosis. All patients were genotyped for rs800292 and rs1329428 variants of CFH using TaqMan technology. On the initial presentation, female patients were significantly older (p = 2.1 × 10 –4 , female 61.6 ± 12.4 vs male 55.1 ± 11.3) and had thinner subfoveal choroidal thickness (p = 3.8 × 10 –5 ) and higher central retinal thickness (p = 3.0 × 10 –3 ) compared to males. A descending tract was more frequently seen in males than in females (p = 8.0 × 10 –4 , 18.1% vs 0%). Other clinical characteristics were comparable between the sexes. The risk allele frequency of both variants including CFH rs800292 and CFH rs1329428 was comparable between males and females ( CFH rs800292 A allele male 51.2% vs female 47.2%, CFH rs1329428 T allele male 56.2% vs 52.8%). On the initial presentation, age, subfoveal choroidal thickness and central retinal thickness differ between males and females in eyes with CSC. A descending tract may be a strong male finding in CSC.
18
Scleral Thickness in Central Serous Chorioretinopathy
Naoya Imanaga, Nobuhiro Terao, Sakari Nakamine et al. · Ophthalmology Retina · 2020 · 131 citations · Full text